Irbesartan HCT Zentiva 150/12.5 mg

Irbesartan HCT Zentiva 150/12.5 mg is a medicine authorised by Swissmedic under authorisation number 62278. The authorisation holder is Helvepharm AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 27 July 2011 and the authorisation is valid without a time limit. ATC code C09DA04 places the medicine in the group Agents acting on the renin-angiotensin system.

  • Dispensing category B
  • Authorisation number 62278
  • ATC C09DA04
  • Synthetic medicines
Authorisation data
Authorisation number62278
NameIrbesartan HCT Zentiva 150/12.5 mg
Full nameIrbesartan HCT Zentiva 150/12.5 mg, Filmtabletten
Authorisation holderHelvepharm AG
Medicinal product codeSynthetic medicines
Dispensing categoryB · Prescription only
ATC codeC09DA04
First authorisation27 July 2011
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Irbesartan HCT Zentiva 150/12.5 mg, FilmtablettenB27 July 2011
2Irbesartan HCT Zentiva 300/12.5 mg, FilmtablettenB27 July 2011
3Irbesartan HCT Zentiva 300/25 mg, FilmtablettenB27 July 2011

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
128Tablette(n)C09DA0402.07.2.B
298Tablette(n)C09DA0402.07.2.B
328Tablette(n)C09DA0402.07.2.B
498Tablette(n)C09DA0402.07.2.B
528Tablette(n)C09DA0402.07.2.B
698Tablette(n)C09DA0402.07.2.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Irbesartan HCT Zentiva 150/12.5 mg authorised in Switzerland?

Yes. Irbesartan HCT Zentiva 150/12.5 mg is authorised by Swissmedic under authorisation number 62278, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Irbesartan HCT Zentiva 150/12.5 mg have?

Irbesartan HCT Zentiva 150/12.5 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Irbesartan HCT Zentiva 150/12.5 mg?

The authorisation holder is Helvepharm AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com